The changes in splicing fidelity elicited by SRPK1 down-regulation in breast and colon tumor cells have been shown to lead to production of aberrant MAP2K2 transcripts and protein, which in turn may reduce the availability of this kinase to phosphorylate its targets MAPK1/2 [19]. Here, SRPK1 is linked to colonic neoplasm.